Mural Oncology plc
MURADelisted Dec 5, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001971543
Mural Oncology plc was delisted on Dec 5, 2025; its insiders filed their last Form 4 on Dec 5, 2025; 61 institutions reported holding it in 13F filings for Q3 2025, worth $11.0M in total; no superinvestor held it.
Holders of 5% or more of MURA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Mural Oncology plc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Acorn Bioventures, L.P. | 13G/A | 7.60%1.29M shares | +1.30 ppfrom 6.30% | Aug 13, 20243 filings | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on Mural Oncology plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 16, 20259:53 AM ET | Trium Capital LLP | 13G/A | 0.00%0 shares | −10.20 ppfrom 10.20%Below 5% | Dec 11, 2025 | SEC |
| Nov 13, 20257:39 PM ET | Prosight Management, LPand 4 others | 13G/A | 0.00%0 shares | −5.20 ppfrom 5.20%Below 5% | Sep 30, 2025 | SEC |
| Nov 7, 20254:00 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 0.00%0 shares | −7.60 ppfrom 7.60%Below 5% | Sep 30, 2025 | SEC |
| Sep 2, 20259:54 AM ET | Trium Capital LLP | 13G | 10.20%1.76M shares | New | Aug 22, 2025 | SEC |
| Aug 14, 20259:17 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 0.00%0 shares | −9.99 ppfrom 9.99%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20253:34 PM ET | Solas Capital Management, LLCand 1 other | 13G/A | 0.00%0 shares | −5.20 ppfrom 5.20%Below 5% | Jun 30, 2025 | SEC |
| Aug 5, 20255:00 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 7.60%1.32M shares | +1.30 ppfrom 6.30% | Jun 30, 2025 | SEC |
| Jun 26, 20255:26 PM ET | Prosight Management, LPand 4 others | 13G | 5.20%900.0K shares | New | Jun 23, 2025 | SEC |
| May 15, 20253:44 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%1.72M shares | +0.03 ppfrom 9.96% | Mar 31, 2025 | SEC |
| May 15, 202511:17 AM ET | Solas Capital Management, LLCand 1 other | 13G/A | 5.20%888.0K shares | −2.20 ppfrom 7.40% | Mar 31, 2025 | SEC |
| May 14, 20255:13 PM ET | Feldman Stuartand 3 others | 13G | 4.40%765.6K shares | NewBelow 5% | Apr 16, 2025 | SEC |
| Apr 16, 20255:37 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G | 6.30%1.08M shares | New | Apr 15, 2025 | SEC |
| Feb 14, 20255:11 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.96%1.70M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202512:18 PM ET | Acorn Bioventures, L.P.and 4 others | 13G/A | 7.60%1.29M shares | +1.30 ppfrom 6.30% | Dec 31, 2024 | SEC |
| Nov 14, 20243:18 PM ET | Solas Capital Management, LLCand 1 other | 13G | 7.40%1.27M shares | New | Sep 30, 2024 | SEC |
| Nov 14, 202412:00 PM ET | Acorn Bioventures, L.P.and 4 others | 13G/A | 6.30%1.08M shares | +1.30 ppfrom 5.00% | Aug 9, 2024 | SEC |
| Aug 13, 20244:43 PM ET | Acorn Bioventures, L.P.and 4 others | 13G | 5.00%848.5K shares | New | Aug 9, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Mural Oncology plc shares.
No Form 144 notices for Mural Oncology plc are on file.